A detailed history of Van Eck Associates Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 611,274 shares of ZTS stock, worth $119 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
611,274
Previous 589,481 3.7%
Holding current value
$119 Million
Previous $99.7 Million 6.24%
% of portfolio
0.15%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$145.54 - $178.83 $3.17 Million - $3.9 Million
21,793 Added 3.7%
611,274 $106 Million
Q1 2024

Apr 30, 2024

BUY
$165.67 - $199.94 $2.21 Million - $2.67 Million
13,363 Added 2.32%
589,481 $99.7 Million
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $11.6 Million - $15.3 Million
-76,470 Reduced 11.72%
576,118 $114 Million
Q3 2023

Nov 08, 2023

SELL
$167.14 - $192.77 $12.1 Million - $14 Million
-72,622 Reduced 10.01%
652,588 $114 Million
Q2 2023

Aug 03, 2023

SELL
$160.94 - $186.23 $11.6 Million - $13.4 Million
-71,920 Reduced 9.02%
725,210 $125 Million
Q1 2023

May 03, 2023

SELL
$145.48 - $175.02 $27.6 Million - $33.2 Million
-189,536 Reduced 19.21%
797,130 $133 Million
Q4 2022

Feb 08, 2023

BUY
$131.14 - $157.47 $3.52 Million - $4.23 Million
26,857 Added 2.8%
986,666 $145 Million
Q3 2022

Oct 27, 2022

SELL
$148.29 - $182.55 $18.7 Million - $23 Million
-125,871 Reduced 11.59%
959,809 $142 Million
Q2 2022

Aug 03, 2022

BUY
$155.97 - $200.09 $40.7 Million - $52.2 Million
261,102 Added 31.66%
1,085,680 $187 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $51.3 Million - $66.1 Million
282,579 Added 52.14%
824,578 $156 Million
Q4 2021

Jan 26, 2022

SELL
$193.69 - $247.03 $6.34 Million - $8.09 Million
-32,739 Reduced 5.7%
541,999 $132 Million
Q3 2021

Nov 03, 2021

SELL
$189.29 - $209.69 $18.4 Million - $20.4 Million
-97,381 Reduced 14.49%
574,738 $112 Million
Q2 2021

Aug 10, 2021

SELL
$155.9 - $187.99 $6.37 Million - $7.68 Million
-40,854 Reduced 5.73%
672,119 $125 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $30.3 Million - $35.7 Million
210,710 Added 41.95%
712,973 $112 Million
Q4 2020

Feb 09, 2021

BUY
$157.07 - $174.35 $13.5 Million - $15 Million
86,049 Added 20.67%
502,263 $83.1 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $4.44 Million - $5.36 Million
-32,411 Reduced 7.22%
416,214 $68.8 Million
Q2 2020

Aug 10, 2020

BUY
$111.92 - $142.53 $3.1 Million - $3.95 Million
27,729 Added 6.59%
448,625 $61.5 Million
Q1 2020

May 12, 2020

SELL
$92.66 - $144.94 $9.15 Million - $14.3 Million
-98,728 Reduced 19.0%
420,896 $49.5 Million
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $427,683 - $490,226
-3,679 Reduced 0.7%
519,624 $68.8 Million
Q3 2019

Nov 08, 2019

SELL
$112.57 - $128.43 $2.89 Million - $3.29 Million
-25,633 Reduced 4.67%
523,303 $65.2 Million
Q2 2019

Aug 07, 2019

SELL
$97.98 - $114.28 $17.7 Million - $20.7 Million
-181,156 Reduced 24.81%
548,936 $62.3 Million
Q1 2019

May 13, 2019

SELL
$81.56 - $100.67 $7.14 Million - $8.81 Million
-87,563 Reduced 10.71%
730,092 $73.5 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $4.47 Million - $5.37 Million
-56,328 Reduced 6.44%
817,655 $69.9 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $1.88 Million - $2.1 Million
22,489 Added 2.64%
873,983 $80 Million
Q2 2018

Aug 13, 2018

SELL
$79.9 - $89.2 $4.17 Million - $4.66 Million
-52,218 Reduced 5.78%
851,494 $72.5 Million
Q1 2018

May 11, 2018

SELL
$71.51 - $84.69 $5.94 Million - $7.04 Million
-83,089 Reduced 8.42%
903,712 $75.5 Million
Q4 2017

Feb 12, 2018

SELL
$63.24 - $72.8 $4.83 Million - $5.56 Million
-76,372 Reduced 7.18%
986,801 $71.1 Million
Q3 2017

Nov 09, 2017

SELL
$59.73 - $65.4 $1.14 Million - $1.25 Million
-19,063 Reduced 1.76%
1,063,173 $67.8 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,082,236
1,082,236 $67.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $91.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.